Pluri PLUR
NASDAQ PLUR
$1.70 -0.06 (-3.41%)
As of: Aug 21, 2026 · 9:30 AM EDT

Pluri (PLUR) EBT Margin (2011 - 2025)

Pluri (PLUR) posted quarterly EBT Margin of 3474.75% for Q4 2025, down 179367.0% year-over-year from N/an in Q4 2024, and down 78.83% quarter-over-quarter from 1943.04% in Q3 2025.

Pluri (PLUR) EBT Margin (2011 - 2025) Analysis & Trends

Pluri (PLUR) has reported EBT Margin for 12 consecutive years, with 3474.75% the latest figure, recorded in Q4 2025.

  • In Q4 2025, EBT Margin fell 179367.0% year-over-year to 3474.75%; the TTM figure through Dec 2025 stood at 1903.36% (up 124148.0% YoY), while the FY2025 annual figure was 1740.64%, up 480660.0% from the prior year.
  • EBT Margin slipped to 3474.75% in Q4 2025 per PLUR's latest filing, from 1943.04% in the prior quarter.
  • Across five years, EBT Margin topped out at 1314.29% in Q1 2025 and bottomed at 423300.0% in Q4 2022.
  • Historically, EBT Margin has averaged 32799.09% across 4 years, with a median of 5170.48% in 2023.
  • On a YoY basis, EBT Margin climbed as much as 41812952 bps in 2023 and fell as far as 483291 bps in 2023.
  • Pluri's EBT Margin stood at 423300.0% in 2022, then jumped by 99 bps to 5170.48% in 2023, then surged by 67 bps to 1681.08% in 2024, then slumped by 107 bps to 3474.75% in 2025.
  • Business Quant data shows PLUR's EBT Margin at 3474.75% in Q4 2025, 1943.04% in Q3 2025, and 1722.11% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 138.04 Bn 130.19 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 85.58 Bn 77.59 Bn 3.93 Bn 35.61%
3 Argenx Se 64.52 Bn 59.34 Bn 1.37 Bn 35.71%
4 Moderna 56.52 Bn 51.38 Bn 52.00 Mn -528.97%
5 BeOne Medicines 42.04 Bn 36.94 Bn 1.53 Bn 18.33%
6 Alnylam Pharmaceuticals 30.67 Bn 27.36 Bn 992.69 Mn 13.77%
7 Insmed 27.27 Bn 26.11 Bn 358.27 Mn -2.67%
8 BioNTech SE 27.14 Bn 8.75 Bn 668.28 Mn -25.06%
9 Royalty Pharma 27.12 Bn 26.28 Bn - 12.09%
10 Pluri 15.74 Mn 3.26 Mn 86,000.00 -3,474.75%

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,474.75%
Sep 30, 2025 -1,943.04%
Jun 30, 2025 -1,722.11%
Mar 31, 2025 -1,314.29%
Dec 31, 2024 -1,681.08%
Sep 30, 2024 -1,851.53%
Jun 30, 2024 -6,512.50%
Mar 31, 2024 -8,343.66%
Dec 31, 2023 -5,170.48%
Sep 30, 2023 -10,353.70%
Jun 30, 2023 -5,390.09%
Mar 31, 2023 -9,166.67%
Dec 31, 2022 -423,300.00%
Sep 30, 2022 -7,428.74%
Mar 31, 2022 -4,333.76%
Dec 31, 2019 -37,230.43%
Dec 31, 2018 -18,220.00%
Sep 30, 2018 -240,950.00%
Dec 31, 2017 -17,466.00%
Dec 31, 2015 -170.02%